New HIV anti-retrovirus regime is coming day by day regularly as new medicines invented and tried, some medicines produce less toxicity as a result better compliance is reached. Some cost less so can be used by poor patients too. Few medicines being new so chances of getting them resistance is low so better correction of CD4 and marked reduction of HIV virus load is seen so better HIV is controlled so patient improves on one hand and gets no side effects on another side.
The US FDA has approved [bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg] as a once-daily single tablet regimen for the treatment of HIV-1 infection in adults. This is mainly for patients who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least three…
